Poland’s competition regulator, the UOKiK, is seeking public comment on proposed amendments to the competition and consumer protection law. The essential changes concern improving the merger control system, detection, and the leniency program.
The UOKiK proposes a two-phase procedure for merger proceedings: a 30-day period for “transactions raising no doubts,” and four months for more complex cases. Moreover, the UOKiK is to inform parties of their concerns during proceedings for complex cases, to give them a chance to be a heard before a decision is to be reached. In addition, the deadline for divestitures required for the UOKiK’s conditional consent will no longer be disclosed, as such public information was found to significantly lower the negotiating position of the divesting party.
A significant proposal is to add individual liability for antitrust violations. The leniency program is also to be expanded to reduce individual fines in exchange for cooperating with the UOKiK in investigations.
The draft amendments are available on the UOKiK website (Polish only). Comments are to be sent by June 5.
Full content: UOKiK Press Release
Related content: Introduction of Leniency Programs for Cartel Participants: The Russian Case (Andrey Shastitko, Bureau of Economic Analysis Foundation, Moscow Lomonossov State University & Svetlana Avdasheva, University-Higher School of Economics in Moscow)
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas